Business Context and Reporting Period
This Form 8-K was filed by iSpecimen Inc. (ISPC) on April 11, 2024, reporting events occurring on April 9, 2024. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Lexington, MA. The filing addresses the status of its Common Stock listing on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
The primary material event is the extension of the compliance period for the Nasdaq Minimum Bid Price Requirement. The Company previously received a deficiency notice on October 9, 2023, for failing to maintain a $1.00 minimum bid price. Although the initial 180-day compliance period expired on April 8, 2024, without the Company regaining compliance, Nasdaq granted an additional 180-day extension.
Outlook, Risks, and Contingencies
- Compliance Deadline: The Company now has until October 7, 2024, to regain compliance with the $1.00 minimum bid price requirement.
- Compliance Criteria: To satisfy the requirement, the closing bid price of the Common Stock must be at least $1.00 per share for a minimum of 10 consecutive business days during the Second Compliance Period.
- Delisting Risk: If compliance is not demonstrated by October 7, 2024, Nasdaq will notify the Company that the Common Stock will be delisted.
- Appeal Process: In the event of a delisting determination, the Company retains the right to appeal to a Hearings Panel.
Investor Verification Checklist
- Verify the current trading price of ISPC stock to assess the likelihood of meeting the $1.00 threshold for 10 consecutive days.
- Monitor the Company's stock price daily between April 9, 2024, and October 7, 2024, for any periods of sustained compliance.
- Review future 8-K filings for any updates on the compliance status or potential reverse stock split announcements.
- Confirm the Company's liquidity position in subsequent quarterly reports (10-Q) to understand its ability to fund operations if delisting occurs.